Internal jugular vein cannulation using 2 silastic catheters. A new, simple and safe long-term vascular access for extracorporeal treatment.
Subclavian vein cannulation, although a major progress in temporary vascular access, was associated with a significant morbidity and mortality. A safer alternative technique would therefore be welcome. For the last 2 years, we developed a new approach consisting in internal jugular vein cannulation (IJVC) with 2 silicone rubber catheters with a long-term proved biocompatibility. 138 pairs of cannulae were inserted in 129 uremics patients. Mean duration of use was 54 days (1 day to 17 months). More than 3,000 high-performance HD sessions were performed. IJVC handling and care was easily managed by nurses. Low incidence of complications was observed: 2 thrombosis episodes, 3 skin infection with 2 septicemiae, 1 air embolism, 1 anaphylactoid reaction. No death was related to the technique itself. IJVC offers a new method of percutaneous central vein cannulation, providing a safe and reliable temporary vascular access immediately usable for all kinds of extracorporeal treatment.
B
B
Canaud
J J
JJ
Beraud
H
H
Joyeux
C
C
Mion
D000328:Adult; D000368:Aged; D000707:Anaphylaxis / Q000209:etiology; D002404:Catheterization / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D004618:Embolism, Air / Q000209:etiology; D005260:Female; D006801:Humans; D007601:Jugular Veins / Q000033:anatomy & histology; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012306:Risk; D012826:Silicone Elastomers; D013207:Staphylococcal Skin Infections / Q000209:etiology; D013211:Staphylococcus aureus; D013924:Thrombophlebitis / Q000209:etiology; D014511:Uremia / Q000628:therapy*
D012826:Silicone Elastomers